Reduced‐Frequency <scp>GLP1</scp> Therapy Maintains Weight, Body Composition, and Metabolic Syndrome Improvements: A Case Series

In patients with prior weight loss and metabolic improvement on GLP1 therapy, reduced-frequency maintenance dosing preserved outcomes. These findings support structured de-escalation as a promising strategy to reduce treatment burden without sacrificing efficacy.